U.S. Govt Eyes Decentralized Clinical Trials For Monkeypox Research

The U.S. government’s monkeypox research team plans to prioritize the use of decentralized clinical trials and remote monitoring to gain more information about the current monkeypox outbreak, the White House announced as part of its broader $140 million monkeypox research plan released late last week. Remote clinical trials played a key part in the COVID-19 pandemic response, allowing vaccine makers to enroll patients from diverse communities and make use of digital tools that allowed researchers to connect with patients via...